A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).Brandon G. Smaglo, Ann M. Leen, Adrian P. Gee et al.|Journal of Clinical Oncology|2020Cited by 15